Atkinson K

No ORCID on file · 1 paper in corpus · active 2019
2019
Scientific reports ·doi:10.1038/s41598-018-37420-x

Pharmaceutical agents currently approved for the treatment of multiple sclerosis reduce relapse rates, but do not reverse or prevent neurodegeneration nor initiate myelin repair. The highly selective estrogen receptor (ER) β ligand chloroin…